CREATe-1
Kv1.3
INNLIFES interview - VRG Therapeutics is the most innovative proposal of MIT4LS 2023

INNLIFES, an Italian online life science journal has published an interview with Tamás Kitka, PhD, our Director of Innovation and Portfolio. It covers VRG-K1, lead molecule of Kv1.3 project and our two proprietary platforms, ISEP and CREATe.
Note: The original language of this interview is Italian and was translated to English using Google Translate.

Introduction
Link icon purple
WRITTEN BY
VRG Therapeutics
PUBLISHED ON
November 6, 2023
SHARE THIS ON
Linkedin purple icon share buttonFacebook purple icon share buttonX purple icon share button
WRITTEN BY
VRG Therapeutics
PUBLISHED ON
November 6, 2023
SHARE THIS ON
Linkedin purple icon share buttonFacebook purple icon share buttonX purple icon share button
Introduction
Link icon purple
Latest
News
The latest industry news, interviews, technologies, and resources.
View All News
Conference
January 28, 2026
By VRG Therapeutics
2026 International Roadshow Begins
White arrow icon up and right direction redirecting to Partner with US page
Team
January 18, 2026
By VRG Therapeutics
New Joiner R&D Director of Dug Discovery
White arrow icon up and right direction redirecting to Partner with US page
Latest
News
The latest industry news, interviews, technologies, and resources.
Conference
January 28, 2026
By VRG Therapeutics
2026 International Roadshow Begins
White arrow icon up and right direction redirecting to Partner with US page
Team
January 18, 2026
By VRG Therapeutics
New Joiner R&D Director of Dug Discovery
White arrow icon up and right direction redirecting to Partner with US page
View All News
Learn More
Million ways to improve life
Learn More
Million ways to improve life